United Kingdom

National
The British National Health Service estimates that 250,000 people in the United Kingdom have myalgic encephalomyelitis. This represents a prevalence of around 0.4% of the UK population.

Doctor Luis Nacul and colleagues found prevalence in some regions of England to be around 0.2% using the 1994 Fukuda criteria, and 0.11% using the stricter Canadian Consensus Criteria.

Regional
Estimated regional figures of people with ME/CFS:
 * 1500 in Shropshire
 * 7000 in Northern Ireland

Research

 * Medical Research Council (MRC)
 * National Institute for Health Research (NIHR)
 * In 1996 a report (see [[File:1996 UK Chronic Fatigue Syndrome report.pdf]]) by the Royal College of Psychiatrists, the Royal College of General Practitioners and the Royal College of Physicians was published that stated "There is consensus on the importance of a biopsychosocial approach to aetiology, assessment, and treatment and the need for further research". It was criticised in a Lancet editorial Frustrating survey of chronic fatigue which stated that "The condition shall now be called chronic fatigue syndrome (CFS) and not myalgic encephalomyelitis(ME), the report decrees" and "The sixteen-strong committee was top heavy with psychiatric experts, so the emphasis on psychological causes and management (introduction of graded exercise and cognitive behaviour therapy) is no surprise"

Medical guidelines

 * National Institute for Health and Care Excellence (NICE, England & Wales)

CBT/GET

 * Cognitive behavioral therapy
 * Graded exercise therapy
 * PACE trial

Social security and disability benefits

 * Department for Work and Pensions (DWP)

Patients are assessed for financial state support based on the Work Capability Assessment. The assessment is based on a handbook.

National Health Service
How many hospitals&doctors, which diagnose and treat M E (estimate): Rehabilitation offers for ME sufferers:


 * National Health Service (NHS)

Private health insurance

 * UNUM

Politics

 * All-Party Parliamentary Group on Myalgic Encephalomyelitis
 * Chief Medical Officer Report 2002
 * Secret files
 * In the Expectation of Recovery report by The Centre for Welfare Reform

Media

 * Science Media Centre (SMC)
 * Sense About Science

Scotland

 * NHS Scotland

National groups
Action for ME, Invest in ME, Change For M.E. Change For Us, ME Association, Tymes Trust, MEActionUK, Forward-ME, Hope 4 ME & Fibro NI, Association of Young People with ME, 25 Percent ME Group, ME Research UK

Regional groups
Welsh Association of ME & CFS Support, Sussex & Kent ME/CFS Society, Tyne and Wear ME/CFS Support Group, Edinburgh MESH, Leeds ME Network, The York ME Community, The Grace Charity for M.E. (Kent)

Research
Government-funded research is limited. Patient Graham McPhee created a video explanation examining UK government funding of ME/CFS research.

2016 government petition for increased funding
A petition was started in early 2016 to ask the British government to allocate more funding to the disease. It attracted 15,400 signatures over a six month period. As the signature count was in excess of 10,000, the government was obliged to respond, and did so as follows:

The Government supports research into Chronic Fatigue Syndrome/Myalgic Encephalomyelitis (CFS/ME) through the Medical Research Council (MRC), which receives funding from the Department for Business, Innovation and Skills; and through the National Institute for Health Research (NIHR), which is funded by the Department of Health. Together the MRC and NIHR welcome high quality applications for research into all aspects of CFS/ME. These would include studies to investigate the biological causes of the condition, improve our understanding of the condition and the complex and diverse range of symptoms experienced, and evaluate treatments.

Research proposals in all areas compete for the funding available with awards made according to their scientific quality and importance to human health.

Research into CFS/ME is a current priority area for the MRC. It received very few high-quality proposals in the area it has implemented a number of initiatives to stimulate more research in this important area and to increase research capacity by bringing new researchers into the field and supporting multidisciplinary teams to tackle research challenges and build partnerships. A highlight notice which outlines research priorities identified by the research community, and where applications are encouraged, is currently in place and can be found on its website at: http://www.mrc.ac.uk/funding/how-we-fund-research/highlight-notices/cfsme-highight-notice/

Notable studies

 * 2011, PACE trial
 * FINE trial
 * 2016, Three Approaches to Chronic Fatigue Syndrome in the United Kingdom, Australia, and Canada: Lessons for Democratic Policy

Research groups
ME Research UK

Researchers

 * Melvin Ramsay
 * Donald Acheson
 * Gordon Parish
 * Jonathan Kerr
 * Amolak Bansal
 * Julia Newton
 * Elizabeth Dowsett
 * Simon Carding
 * James Mowbray
 * John Richardson
 * Luis Nacul
 * Derek Pheby
 * Jonathan Edwards
 * Geraldine Cambridge
 * George Davey Smith
 * Neil Harrison
 * Fane Mensah

Clinicians
Amolak Bansal, Peter Behan, Gabrielle Murphy, Sarah Myhill, Charles Shepherd, Nigel Speight, William Weir

Clinics

 * Breakspear Medical, Hemel Hempstead
 * The Optimum Health Clinic, London

Notable patients
Vicky Beeching, Jane Colby, Shirley Conran, L.A. Cooper, Robert Courtney, Clark Ellis, Catherine Hale, Nasim Marie Jafry, Peter Kemp, Countess of Mar, Tanya Marlow, Graham McPhee, Giles Meehan, Stuart Murdoch, Ean Proctor, Charles Shepherd, Valerie Eliot Smith, Jessica Taylor, Claire Wade, Naomi Whittingham, Doctor Speedy

Deceased patients
Oliver Coles, Emily Collingridge, Victoria Elsbury-Legg, Lynn Gilderdale, Sophia Mirza

Learn more

 * The Hidden Battle For The Rights Of Chronic Fatigue Syndrome Sufferers